Probiotic supplement study for breast cancer patients
Part of Cancer, Skin clinical trials.
This study tests whether taking a probiotic supplement affects the bacteria and fungi in your gut, which may be linked to your breast cancer. You'll take a daily probiotic and have your diet and activity stay the same, to see if it helps your body respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman over 18 years old
- You have invasive breast cancer (ductal or lobular) with a tumor at least 1 cm
- You can use birth control if you could become pregnant
- You agree to avoid probiotics and certain fermented foods during the study
- You have not used antibiotics in the last 5 weeks
- You have no serious digestive conditions like inflammatory bowel disease or ulcers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a probiotic supplement can help breast cancer patients going through chemotherapy. If you are between 20 and 80 years old, have stage I-III breast cancer, and are receiving certain chemo drugs, this study may be for you.
This trial tests whether a special probiotic supplement (good bacteria) can reduce belly discomfort caused by abemaciclib, a hormone therapy drug for early breast cancer. You would take the supplement alongside your cancer treatment to see if it helps with stomach side effects.
This study looks at how a dietary supplement (resistant starch) affects your gut bacteria while you take the breast cancer drug abemaciclib (Verzenio). It may help reduce side effects and improve your quality of life during treatment.
This study looks at the link between weight loss (cachexia) and gut bacteria in women with breast cancer who are getting home care. It may help doctors understand and improve symptoms like weight loss in the future.
This study looks at how bacteria in your gut might relate to breast cancer. By comparing tissue samples from your tumor and nearby healthy tissue, researchers hope to find new ways to understand or treat breast cancer.
This trial tests adding an immunotherapy drug to standard chemotherapy before surgery for triple-negative breast cancer. The goal is to see if this combination works better than chemotherapy alone.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.